Axa Raises Position in Stryker Corporation (SYK)

Axa boosted its position in shares of Stryker Corporation (NYSE:SYK) by 6.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 516,156 shares of the medical technology company’s stock after acquiring an additional 31,375 shares during the period. Axa owned approximately 0.14% of Stryker worth $73,304,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Renaissance Technologies LLC acquired a new stake in Stryker during the first quarter valued at approximately $948,000. Xact Kapitalforvaltning AB boosted its holdings in Stryker by 0.8% during the second quarter. Xact Kapitalforvaltning AB now owns 52,681 shares of the medical technology company’s stock valued at $7,311,000 after purchasing an additional 427 shares in the last quarter. Stock Yards Bank & Trust Co. acquired a new stake in Stryker during the second quarter valued at approximately $212,000. Atria Investments LLC boosted its holdings in Stryker by 9.7% during the second quarter. Atria Investments LLC now owns 6,815 shares of the medical technology company’s stock valued at $946,000 after purchasing an additional 604 shares in the last quarter. Finally, Private Trust Co. NA boosted its holdings in Stryker by 1.8% during the second quarter. Private Trust Co. NA now owns 23,506 shares of the medical technology company’s stock valued at $3,262,000 after purchasing an additional 418 shares in the last quarter. Hedge funds and other institutional investors own 74.97% of the company’s stock.

A number of equities research analysts have weighed in on the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Stryker in a report on Thursday, December 7th. Royal Bank of Canada reaffirmed a “buy” rating and set a $155.00 price objective on shares of Stryker in a report on Monday, October 2nd. BidaskClub raised Stryker from a “hold” rating to a “buy” rating in a report on Thursday, August 17th. BMO Capital Markets raised Stryker to a “market perform” rating and set a $163.00 price objective on the stock in a report on Tuesday. Finally, SunTrust Banks reaffirmed a “buy” rating and set a $161.00 price objective on shares of Stryker in a report on Monday, October 2nd. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and thirteen have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $153.19.

In other Stryker news, insider Lonny J. Carpenter sold 5,000 shares of the company’s stock in a transaction on Friday, November 3rd. The stock was sold at an average price of $155.34, for a total transaction of $776,700.00. Following the transaction, the insider now owns 83,207 shares of the company’s stock, valued at approximately $12,925,375.38. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 7.40% of the stock is currently owned by corporate insiders.

Stryker Corporation (NYSE:SYK) traded down $1.97 during trading hours on Friday, reaching $151.34. The company’s stock had a trading volume of 1,406,700 shares, compared to its average volume of 1,178,710. Stryker Corporation has a 12-month low of $116.50 and a 12-month high of $160.62. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.61 and a current ratio of 2.37. The firm has a market cap of $57,374.37, a P/E ratio of 24.30, a price-to-earnings-growth ratio of 2.41 and a beta of 0.78.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, October 26th. The medical technology company reported $1.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.50 by $0.02. Stryker had a return on equity of 24.11% and a net margin of 14.67%. The firm had revenue of $3.01 billion for the quarter, compared to the consensus estimate of $2.97 billion. During the same quarter in the prior year, the business earned $1.39 EPS. The business’s revenue for the quarter was up 6.1% compared to the same quarter last year. analysts forecast that Stryker Corporation will post 6.47 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 31st. Shareholders of record on Friday, December 29th will be issued a dividend of $0.47 per share. This is an increase from Stryker’s previous quarterly dividend of $0.43. The ex-dividend date is Thursday, December 28th. This represents a $1.88 annualized dividend and a yield of 1.24%. Stryker’s dividend payout ratio is currently 36.32%.

COPYRIGHT VIOLATION NOTICE: “Axa Raises Position in Stryker Corporation (SYK)” was reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The correct version of this story can be read at https://www.com-unik.info/2017/12/15/axa-raises-position-in-stryker-corporation-syk.html.

About Stryker

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

What are top analysts saying about Stryker? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Stryker and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit